EMA Defines Actions For Using CAR-T Registries For Regulatory Evaluation

A multi-stakeholder EU workshop has helped identify how patient registries can support the benefit-risk evaluation of CAR-T cell therapies, given the challenges posed by these products, not least the need for the long-term follow up of treated patients.

T-cells attacking cancer_1200x675
Registries Can Help Generate Post-Market Data On CAR-T Therapies • Source: Shutterstock

The European Medicines Agency has issued several recommendations to help facilitate and improve the use of patient registry data to support the evaluation of chimeric antigen receptor T-cell (CAR T-cell) therapies.

The recommendations, which include introducing a method for the systematic collection of a set of core commonly-defined data elements, follow...

Welcome to Pink Sheet

Create an account to read this article

More from Europe

EU-Level Efforts To Mitigate Drug Shortages Unsuccessful, Audit Reveals

 

Actions taken by the European Commission and European Medicines Agency to tackle critical shortages of medicines have not succeeded in practice and further systemic improvements are required to address supply issues, a report from the European Court of Auditors has found.

Canada, Britain And Australia Push For Greater International Regulatory Alignment

 

Canada’s drug regulator is using amended drug laws to increase the use of regulatory reliance pathways to improve efficiency and support international alignment, while the UK’s MHRA has held talks with Australia’s TGA on topics including the role of AI in regulatory frameworks.

Sanofi’s Rilzabrutinib & Belumosudil Among Seven Drugs Facing EMA Oral Explanations

 
• By 

The sponsors of seven new medicines nearing the end of their EU regulatory review are due – or possibly due – to appear before the European Medicines Agency’s human medicines committee, the CHMP, to address remaining concerns about their marketing applications.

EU’s Draft GMP Guideline Signals Major Cultural Shift In Pharma Quality Compliance

 
• By 

While the EU's draft good manufacturing practice guideline on pharmaceutical quality systems reflects modern quality management principles, it also presents significant operational and resource challenges for drug companies.

More from Geography

Canada, Britain And Australia Push For Greater International Regulatory Alignment

 

Canada’s drug regulator is using amended drug laws to increase the use of regulatory reliance pathways to improve efficiency and support international alignment, while the UK’s MHRA has held talks with Australia’s TGA on topics including the role of AI in regulatory frameworks.

Publisher’s Spotlight: Shortlist Unveiled For Citeline Japan Awards

 
• By 

Shortlists of potential winners in all categories of the Citeline Japan Awards 2025 have now been released. Join us at the event in Tokyo on October 21, it’s not too late to book your table!

Ex-CDC Leaders Reveal New Details Of Kennedy’s Plans For ACIP, Vaccine Schedule

 

The former CDC director and recently departed chief medical officer tell senators that Kennedy plans to target the childhood vaccine schedule despite a lack of scientific data to support his agenda.